on-demand webinar & presentation.

Oral Solid Dose Manufacturing:

Expanding the OSD toolbox with an industry-based approach to lipid and surfactant adsorption onto dry powder excipients to increase the dissolution rate of BCS Class II or Class IV active pharmaceutical ingredients (API’s)

⬇️ Complete the form to download




In this presentation, viewers can expect to learn:

  • Dissolution and bioavailability enhancement techniques for BCS Class II and IV API’s incorporated within tablet matrices
  • Ease of scalability using conventional OSD technologies obviating the need for other complex methods of manufacture
  • Linking the platform to multiple types of presentations (capsules, ODTs, granules/pellets, mini tablets, etc.)

Bobby Sciscento, Sr Scientist, Formulations

Saujanya Gosangari, Trevor Williams, Allan Bean, Tres Harris

Presented at CPhI North America 2024

Complete the form to view the webinar recording and download the presentation.